Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Canada Health Canada updates cannabis/hemp web page with regulatory changes ...
  • Netherlands Coffee shops ask for delay of experimental phase of cannabis experiment ...
  • South Africa Ban on cannabis edibles sparks legal challenges ...
  • United States FDA issues warning to firm marketing intravenous form of CBD ...
  • Moldova First authorisation for hemp cultivation issued ...
  • Ireland Bishops urge government to ban sale of HHC vapes ...
  • Germany Lower Saxony minister says cannabis legislation fails to curb crime ...
  • Germany Lower Saxony court rejects classification of hemp as food ...
  • France Health minister confirms extension of medical cannabis trial ...
  • World UN places HHC in Schedule II of Convention on Psychotropic Substances ...
  • Portugal EC clarifies that CBD classification contradicts EU law ...
  • Lithuania Seimas adopts Fibre Hemp Law amendment ...
View all
News analysis

CBD medicines could be approved in Philippines without need of new law

Written by || 10th March 2020 || News analysis | Policy and Politics | Regulation and legislation | GeographiesAsia Philippines

Legislative efforts will continue to push for cannabinoid liberalisation in the Philippines – despite recent comments that approval in principle of the epilepsy drug Epidiolex would be sufficient to cover most matters
Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.